| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |